Page 13 - ரேர் நிபந்தனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ரேர் நிபந்தனைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ரேர் நிபந்தனைகள் Today - Breaking & Trending Today

Commerce Resources Corp. Engages Engineering Firms to Advance Prefeasibility Study for the Ashram Rare Earth & Fluorspar Deposit


(1)
VANCOUVER, BC / ACCESSWIRE / April 5, 2021 /
Commerce Resources Corp. (TSXV:CCE)(FSE:D7H0)(OTCQX:CMRZF) (the Company or Commerce ) is pleased to provide an update on the progress of the Prefeasibility Study (PFS) for the Ashram Rare Earth and Fluorspar Deposit. The Company is pleased to announce that it has engaged several specialized engineering firms to advance the remaining key components of the PFS through to completion.
The Company has retained DRA Americas Inc. and L3 Process Development for review and assessment of the Ashram Deposit s flowsheet. The selection maintains the direct involvement of several key metallurgical Qualified Persons (QPs) who have a strong familiarity with the specifics of the flowsheet through past work programs. ....

Koksoak River , British Columbia , Darrenl Smith , National Instrument , Dahrouge Geological Consulting Ltd , Company Or Commerce , Venture Exchange , Regulation Services Provider , Commerce Resources Corp , Americas Inc , Commerce Resources , Pre Feasibility Study , Ashram Rare Earth , Ashram Deposit , Qualified Persons , Preliminary Economic Assessment , Social Impact Assessment , Ashram Project , Qualified Person , Fluorspar Deposit , பிரிட்டிஷ் கொலம்பியா , தேசிய கருவி , தஹரொஊகே புவியியல் ஆலோசனை லிமிடெட் , நிறுவனம் அல்லது வர்த்தகம் , துணிகர பரிமாற்றம் , ஒழுங்குமுறை சேவைகள் வழங்குநர் ,

Passage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of Krabbe Disease


- Urgency for effective treatment underscored by European Commission designation for investigational gene therapy PBKR03
- Global Phase 1/2 trial – GALax-C – PBKR03 planned to initiate in first half of 2021
PHILADELPHIA, April 05, 2021 (GLOBE NEWSWIRE) Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for rare monogenic central nervous system (CNS) disorders, today announced that the European Commission has granted Orphan designation for PBKR03, an adeno-associated virus (AAV)-delivery gene therapy for the treatment of Krabbe disease (Globoid Cell Leukodystrophy). The designation was based on a positive opinion from the European Medicines Agency Committee for Orphan Medicinal Products. Currently, there are no approved disease-modifying therapies available for Krabbe disease, a rare lysosomal storage disease that most often presents early in a child’s life. The U.S. Food and Drug Administrat ....

University Of Pennsylvania , United States , Gwen Fisher , Stuart Henderson , Bruce Goldsmith , Exchange Commission , University Of Pennsylvania Gene Therapy Program , European Union , European Commission , Drug Administration , Passage Bio Inc , Globoid Cell Leukodystrophy , European Medicines Agency Committee , Orphan Medicinal , Fast Track , Orphan Drug , Rare Pediatric Disease , Passage Bio , Gene Therapy Program , Private Securities Litigation Reform Act , Risk Factors , Bio Investors , Bio Media , Inc Stock Exchange , Press Release , Designation Pasg ,

Covid 19 coronavirus: Melbourne man's blood clot condition 'likely' linked to vaccine, but rollout to continue


Covid 19 coronavirus: Melbourne man s blood clot condition likely linked to vaccine, but rollout to continue
3 Apr, 2021 06:04 AM
2 minutes to read
Pharmacist Mario Linaksita, right, administers the AstraZeneca Covid-19 vaccine to Sharon Berringer, 56, at University Pharmacy, in Vancouver, British Columbia. Photo / AP
Pharmacist Mario Linaksita, right, administers the AstraZeneca Covid-19 vaccine to Sharon Berringer, 56, at University Pharmacy, in Vancouver, British Columbia. Photo / AP
news.com.au
By: Anton Nilsson
Australian health officials will continue to administer AstraZeneca coronavirus vaccinations after a Melbourne man who had received the jab fell ill with a rare blood clotting condition.
The Friday hospitalisation prompted an urgent meeting of independent experts on Saturday morning. ....

United Kingdom , Michael Kidd , Australian Technical Advisory Group On Immunisation , Therapeutic Goods Administration , Australian Technical Advisory Group , Co Vid , Corona Virus , ஒன்றுபட்டது கிஂக்டம் , மைக்கேல் கிட் , இணை வித் , கொரோனா வைரஸ் ,

Covid 19 coronavirus: Warning after man in Victoria, Australia, develops blood clots following vaccine


Covid 19 coronavirus: Warning after man in Victoria, Australia, develops blood clots following vaccine
2 Apr, 2021 06:43 AM
4 minutes to read
The World Health Organisation and the EU s health watchdog have both deemed the AstraZeneca vaccine, pictured, safe after fears were raised of the jab having serious side effects. Photo / AP
The World Health Organisation and the EU s health watchdog have both deemed the AstraZeneca vaccine, pictured, safe after fears were raised of the jab having serious side effects. Photo / AP
news.com.au
A Victorian man has been admitted to hospital with a rare blood clotting disorder just a few days after receiving the AstraZeneca vaccine. ....

Michael Kidd , Australian Technical Advisory Group , European Medicines Agency , Australian Technical Advisory Group On Immunisation , Therapeutic Goods Administration , World Health Organisation , Chief Medical Officer Professor Michael Kidd , Box Hill Hospital , Good Friday , Co Vid , Corona Virus , மைக்கேல் கிட் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , தலைமை மருத்துவ அதிகாரி ப்ரொஃபெஸர் மைக்கேல் கிட் , பெட்டி மலை மருத்துவமனை , நல்ல வெள்ளி , இணை வித் , கொரோனா வைரஸ் ,